Metraipolis › archive › dc_01ec8986b382

Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction — Europe PMC PMID:40838516

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40838516
DOI
10.1002/anie.202508121
License (as archived)
solo-consultazione
Archived
2026-11-10T10:46:18.083Z
SHA-256 of the archived text
bb17ebf03fbec1efaa1ebab3dd8a0294fc97610577cc6b4e36cd21e258511ef6
Stable URL of this page
https://metraipolis.com/documento/dc_01ec8986b382

How to cite

Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction — Europe PMC PMID:40838516 — Europe PMC (en), https://europepmc.org/article/MED/40838516 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01ec8986b382 (Metraipolis archive dc_01ec8986b382, sha256 bb17ebf03fbec1efaa1ebab3dd8a0294fc97610577cc6b4e36cd21e258511ef6)
BibTeX
@misc{dc01ec8986b382,
  title = {Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction — Europe PMC PMID:40838516},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40838516},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01ec8986b382; sha256 bb17ebf03fbec1efaa1ebab3dd8a0294fc97610577cc6b4e36cd21e258511ef6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40838516. Agents can read the archived copy with the MCP tool read_document.